NCT06448910 2025-09-24Cadonilimab(AK104) Plus Concurrent Chemoradiotherapy in Patients With Locally Advanced, Unresectable, Stage III NSCLCFudan UniversityPhase 2 Active not recruiting41 enrolled
NCT06944470 2025-04-25JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLCShanghai Junshi Bioscience Co., Ltd.Phase 2 Not yet recruiting76 enrolled